Project Grant HT94252410205
Award Date
6/15/24
Completion Date
6/14/28
Dollars Obligated
$1.8M
Federal Agency
Defense Health Agency
Awardee
Inotiv, Inc. (QYU7HDLDQK16)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
Yale University received a $1,731,409 project grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
Yale University received a $1,618,571 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The award will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $5,099,737.00 in funding to 149 Bio LLC, a for-profit organization based in Miami, Florida. The grant supports the development of a "MYELOID-TARGETED NOVEL THERAPEUTIC FOR GLOMERULAR DISEASES", with a project period from July 1, 2025 to June 30, 2029. The funded research aims to transform healthcare for military service members and the...
The U.S. Defense Health Agency awarded a $1,209,369 Project Grant to the Midwest Veterans Biomedical Research Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to investigate the role of the SH3BP2 protein in the immunopathogenesis of nephrotic syndrome. The project will be conducted over a 4-year period from September 1, 2024 to August 31, 2028. The Midwest Veterans Biomedical Research Foundation, a non-profit organization, will...
The Department of the Army Medical Command awarded Yale University a $2,639,485 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from December 2021 through November 2025 to investigate inhibition of the IRE1alpha-XBP1 pathway using toyocamycin as a novel approach to inhibit progression of autosomal dominant polycystic kidney and liver disease. The Military Medical Research and Development program supports basic, applied, and...
This federal Project Grant award, with a total funding amount of $999,972.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to study urine macrophages in lupus nephritis, with the goal of shedding light on kidney disease processes. The research is being conducted by The Feinstein Institutes for Medical Research, a leading non-profit medical research organization, from July 1, 2025 through June...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $2,531,888 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to study "CORRECTING CYTOSKELETAL ABNORMALITIES AND PODOCYTE VULNERABILITY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS." The 4-year award, starting on May 1, 2024, supports Bidmc's research aimed at improving treatments for this kidney disorder. As a leading academic medical center, Bidmc has an...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
The U.S. Department of Defense's Defense Health Agency awarded a $395,202 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "PET IMAGING OF HIF 2A IN RENAL CANCER," supports research to develop new imaging techniques for detecting and monitoring kidney cancer in military personnel and veterans. The three-year award, running from September 1, 2023 to August...
The U.S. Department of the Army Medical Command awarded a $1,640,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The University of Texas Southwestern Medical Center (UT Southwestern) for the project "Therapeutic Parameters and Mechanism of Action of Anti-miR-17 Drugs in ADPKD". The 4-year grant, with a performance period from April 1, 2025 to March 31, 2029, will fund research to investigate innovative therapeutic approaches and disease...